Based on a new study, individuals with ME/CFS had less butyrate-producing bacteria in their guts. Dysbiosis has been known to play an important role in ME/CFS, and the results of this study support this claim. In this study, a metabolomic analysis was done on 91 healthy individuals and 106 ME/CFS patients. In general, the researchers found a shift in the microbiome's diversity in individuals with ME/CFS. Both strains of the bacteria Faecalibacterium prausnitzii and Eubacterium rectale, which synthesize butyrate, were reduced in the ME/CFS individuals. Butyrate is widely recognized for preventing "leaky gut" by strengthening tight junctions to protect the inner membrane of the intestines. According to Canani, "Butyrate plays a regulatory role on the transepithelial fluid transport, ameliorates mucosal inflammation and oxidative status, reinforces the epithelial defense barrier and modulates visceral sensitivity and intestinal motility." In this study, Guo adds that the numbers inversely correlated with the severity of fatigue in the ME/CFS participants.
Source: 1) Potential Beneficial Effects of Butyrate in Intestinal and Extraintestinal Diseases. Roberto Berni Canani, Margherita Di Costanzo, Ledovina Leone, et al. World Journal of Gastronomy. March 28, 2011; 17(12) 1519-1528.

Comments
Post a Comment